immunAware ApS: Financial statements 2020
CVR: 39189135
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
immunAware ApS (CVR 39189135) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,395,210 and a net result of DKK 1,211,357 compared with DKK 1,388,135 the year before. That is an increase of 4.9% compared with the year before. Equity in the 2020 report amounted to DKK 2,590,727. The solvency ratio was 79.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,395,210
- Profit/Loss
- DKK 1,211,357
- Equity
- DKK 2,590,727
- Total Assets
- DKK 3,246,748
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 2.4 mio. | 1.2 mio. | 2.6 mio. | 1 |
| 2019 | - | 2.3 mio. | 1.4 mio. | 1.5 mio. | 1 |
| 2018 | - | 25 t. | 19 t. | 151 t. | 0 |
How creditworthy is immunAware ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ImmunAware ApS has published its annual report for 2019. Gross profit came to DKK 2,283,575, and the net result was DKK 1,388,135.
About immunAware ApS
immunAware ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Buus, Anette Stryhn Buus and Thomas Østerbye. The company is owned by PROSAL ApS, ASTIM Holding ApS and T.Ø. Holding ApS. In 2025, the company reported a gross profit of DKK 4,626,954 and a net result of DKK -338,581 compared with DKK -757,428 the year before. Equity in the 2025 report amounted to DKK 4,913,587.